Organogenesis Holdings Inc
ORGO
$1.13-0.88%
Delayed · as of Oct 15, 2026, 10:16 AM ET
Mkt cap
$301.10M
EV/Sales
0.37
P/E ratio
N/A
FY2025 Revenue
$564.17M
EPS (H1 2026)
$-1.21
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
6.56%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ORGO revenue for 2025-12-31 was $564.2M. Net income was $37.0M. Revenue was up 17.0% from 2024-12-31 to 2025-12-31. ORGO currently screens at market cap $301.1M.
Use this ORGO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ORGO income, balance, and cash tables.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Organogenesis Holdings Inc (ORGO) revenue for Dec 31, 2025 was $564.2M. Net income was $37.0M. Statements: https://lician.com/financials/orgo
Organogenesis Holdings Inc (ORGO) market capitalization is $301.1M on the latest cached snapshot.
Organogenesis Holdings Inc (ORGO) cached previous close $1.14; day range $1.13 – $1.14; volume 72,104. Session quote: https://lician.com/quote/orgo
Organogenesis Holdings Inc (ORGO) latest cached earnings event is "ORGO earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ORGO filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/orgo